Most viewed recently
- CHEK LING. Unleashing the White Australia virus
- MUNGO MACCALLUM. Angus Taylor’s thought bubbles: from the second rate to the already discredited
- PAUL PERVERSI. Understanding anti-China Bias and other prejudices
- RAMESH THAKUR. Coronavirus data prove Australia is in Asia
- SATURDAY’s GOOD READING AND LISTENING FOR THE WEEKEND
- DAVID SOLOMON. They should have said: No Minister
- JOSEPH A. CAMILLERI. Can we rescue the China relationship from the abyss?
- STUART REES. Cowardice as a principle of foreign policy, what on earth are they thinking?
- ALEX MITCHELL. Don Harwin becomes cactus
- MUNGO MACCALLUM. The miracle of being two-faced and saving both faces
Tag Archives: Hazel Moir
A low standard for granting patents can mean lengthy delays generic medicine availability. In one case this is shown to have cost taxpayers almost $A3 billion extra in Pharmaceutical Benefits Scheme outlays. A solution is to grant patents only for … Continue reading
Efforts by pharmaceutical companies to extend their patents cost taxpayers millions of dollars each year. In some cases they also mean people are subjected to unnecessary clinical trials. Big pharma makes big profits. Their useful new drugs are patented, protecting … Continue reading
Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of negotiations towards the new and controversial Trans-Pacific Partnership. In this Free Trade Scorecard series, we review Australian trade policy over the years and where we … Continue reading